Ozempic frena la enfermedad renal en personas obesas

riñones

Puntos clave

  • La semaglutida parece proteger contra la enfermedad renal en personas obesas

  • Tomar el medicamento redujo el daño renal hasta en un 52%

  • Los pacientes también tuvieron una reducción del 30% en la inflamación renal

Originally published on spanish.healthday.com, part of the BLOX Digital Content Exchange.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.